Oxytocin Levels and Parent Child Interaction Therapy for Parental Stress and Attachment
Data Collection
Anxiety Disorders+5
+ Autonomic Nervous System Diseases
+ Behavior
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: February 14, 2025
Actual date on which the first participant was enrolled.This study aims to explore the potential benefits of Parent Child Interaction Therapy (PCIT) on self-reported stress and autonomic and neuroendocrine functioning in parents. It focuses on parents who have experienced various types of traumatic experiences, such as childhood adversity, maltreatment, and health situations. The research team uses well-validated self-report measures of mental health, autonomic reactivity, parental stress, attachment, and non-invasive measurements of levels of oxytocin to accomplish their goals. The study's importance lies in understanding how PCIT can help parents better manage stress and improve their relationships with their children. Throughout the study, participants will complete self-report questionnaires and provide salivary samples for oxytocin level assessment. The questionnaires measure various aspects, including the impact of adversity history, anxiety, autonomic reactivity, child behavior, depression, parental attachment, parental stress, and post-traumatic stress symptoms. By examining these measures before and after PCIT, the study will evaluate the therapy's effectiveness in improving parental stress, parent-child attachment, and parental neuroendocrine functioning. The study also investigates individual characteristics that may influence the effectiveness of PCIT, such as stress and prior adversity.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.80 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 89 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
UF Health Psychiatry San Jose
Jacksonville, United States